1415456-99-3
- Product Name：Cagrilintide
- Molecular Formula：C194H312N54O59S2
- Purity：99%
- Molecular Weight：4409.01
Product Details:
CasNo： 1415456-99-3
Molecular Formula： C194H312N54O59S2
Appearance： White or off-white powder
Delivery Time： Prompt from stock
Packing： Aluminum bag
Throughput： 10KG/Month
Purity： 99%
|
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity[1][2][3]. |
|||||||||||||||||||||||||||||||||||||||||||||||||||
| In Vivo |
Cagrilintide (compound 23) (0.1, 1, 3, 10, 30 nmol/kg; s.c.) reduces food intake in the rat[2]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Trial |
|
Relevant Products
-
SparsentanCAS：254740-64-2
-
Teriparatide acetateCAS：52232-67-4
-
PevonedistatCAS：905579-51-3
